Company newsroom

IDEAYA Biosciences, Inc.

NASDAQ:IDYA

2 releases

IDEAYA Biosciences, Inc.Nov 4, 2026

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,…

IDEAYA Biosciences, Inc.Nov 3, 2026

Data presented at ESMO 2026 collectively supports the potential of darovasertib to become a foundational new therapy across the treatment journey of…